Spatial heterogeneity of lung perfusion assessed with 13N PET as a vascular biomarker in chronic obstructive pulmonary disease
Although it is known that structural and functional changes in the pulmonary vasculature and
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
Spatial Heterogeneity of Lung Perfusion Assessed with^ sup 13^ N PET as a Vascular Biomarker in Chronic Obstructive Pulmonary Disease
MFV Melo, T Winkler, RS Harris… - The Journal of …, 2010 - search.proquest.com
Although it is known that structural and functional changes in the pulmonary vasculature and
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
[PDF][PDF] Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in Chronic Obstructive Pulmonary
MFV Melo, T Winkler, RS Harris, G Musch… - J Nucl …, 2010 - researchgate.net
Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in
Chronic Obstructive Pulmonary Disease Page 1 Spatial Heterogeneity of Lung Perfusion …
Chronic Obstructive Pulmonary Disease Page 1 Spatial Heterogeneity of Lung Perfusion …
Spatial heterogeneity of lung perfusion assessed with 13N PET as a vascular biomarker in chronic obstructive pulmonary disease
MFV Melo, T Winkler, RS Harris, G Musch… - Journal of Nuclear …, 2010 - profiles.wustl.edu
Although it is known that structural and functional changes in the pulmonary vasculature and
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
[引用][C] Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in Chronic Obstructive Pulmonary Disease
MFV Melo, T Winkler, RS Harris, G Musch… - Journal of Nuclear …, 2009 - cir.nii.ac.jp
Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in
Chronic Obstructive Pulmonary Disease | CiNii Research CiNii 国立情報学研究所 学術情報 …
Chronic Obstructive Pulmonary Disease | CiNii Research CiNii 国立情報学研究所 学術情報 …
Spatial heterogeneity of lung perfusion assessed with (13) N PET as a vascular biomarker in chronic obstructive pulmonary disease.
VM MF, T Winkler, RS Harris, G Musch… - Journal of Nuclear …, 2009 - europepmc.org
Methods We studied 6 patients with mild or moderate COPD and 9 healthy subjects (6
young and 3 age-matched). The PET (13) NN-labeled saline injection method was used to …
young and 3 age-matched). The PET (13) NN-labeled saline injection method was used to …
[HTML][HTML] Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in Chronic Obstructive Pulmonary Disease
MFV Melo, T Winkler, RS Harris, G Musch… - Journal of nuclear …, 2010 - ncbi.nlm.nih.gov
Although it is known that structural and functional changes in the pulmonary vasculature and
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
Spatial heterogeneity of lung perfusion assessed with (13) N PET as a vascular biomarker in chronic obstructive pulmonary disease
MFV Melo, T Winkler, RS Harris… - Journal of nuclear …, 2010 - pubmed.ncbi.nlm.nih.gov
Although it is known that structural and functional changes in the pulmonary vasculature and
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
[PDF][PDF] Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in Chronic Obstructive Pulmonary Disease
MFV Melo, T Winkler, RS Harris, G Musch… - J Nucl …, 2010 - Soc Nuclear Med
Although it is known that structural and functional changes in the pulmonary vasculature and
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
parenchyma occur in the progress of chronic obstructive pulmonary disease (COPD) …
Spatial heterogeneity of lung perfusion assessed with (13) N PET as a vascular biomarker in chronic obstructive pulmonary disease.
VM MF, T Winkler, RS Harris, G Musch… - Journal of Nuclear …, 2009 - europepmc.org
Methods We studied 6 patients with mild or moderate COPD and 9 healthy subjects (6
young and 3 age-matched). The PET (13) NN-labeled saline injection method was used to …
young and 3 age-matched). The PET (13) NN-labeled saline injection method was used to …